Immunologic Function and Virologic Suppression Among Children With Perinatally Acquired HIV Infection on Highly Active Antiretroviral Therapy
Bibliographic Data
| ID | 9103060 |
|---|---|
| Authors | Richard M Rutstein (Children's Hospital of Philadelphia, corresponding author), Kelly A Gebo (0000-0003-4010-398X, Johns Hopkins Medicine), Patricia M Flynn (0000-0002-9828-6160, St. Jude Children's Research Hospital), John A Fleishman (Agency for Healthcare Research and Quality), Victoria L Sharp, Victoria Sharp (0000-0003-3690-2615, St. Luke's-Roosevelt Hospital Center), George K Siberry (0000-0002-5999-1596, Johns Hopkins University), Stephen A Spector (0000-0002-1882-4855, University of California San Diego) |
| Year | 2005 |
| Volume | 43 |
| Issue | 9 |
| Pages | III-15 |
| Publication date | 2005-09-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | Medical Care (JOURNAL) |
| Journal identifiers | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Publisher | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/01.mlr.0000175636.34524.b9 |
| PMID | 16116305 |
| OpenAlex | W2091351835 |
| Language | EN |
| Citations received | 2 |
| References cited | 31 |
BACKGROUND: The goal of highly active antiretroviral therapy (HAART) has been to stabilize and reconstitute immune function and suppress viral replication to the greatest degree possible. Suppression of HIV viral replication has been associated with improved long-term and short-term prognosis. Limited data are available on the level of virologic suppression and immune function of pediatric patients followed in clinical settings in the HAART era. OBJECTIVE: The objective of this study was to assess the level of virologic suppression and immune function in a cohort of children with perinatally acquired HIV infection followed at dedicated HIV specialty care sites. RESEARCH DESIGN: This study comprised a cohort study of HIV-infected children and adolescents. SUBJECTS: Study subjects consisted of 263 HIV-positive children ( 25; only 4.2% had CD4 100,000 cpm and severe immunosuppression. Patients who were less likely to achieve virologic suppression to <400 cpm included those with CD4 count <200 cells/mm(3) (odds ratio [OR], 0.06; 95% confidence interval [CI], 0.007-0.46), those with AIDS (OR, 0.5; 95% CI, 0.28-0.94), and those with moderate (OR, 0.42; 95% CI, 0.22-0.79), or severe immunologic suppression (OR, 0.14; 95% CI, 0.046-0.43) based on CD4%. CONCLUSION: In this multisite, pediatric cohort, the rate of near-complete virologic suppression (<50 or <400 cpm) was low. However, the majority of patients have near-normal CD4 counts and viral loads <15,000 cpm. Follow up will be critical to assess the implications of ongoing low-level viral replication with near-normal CD4 values
Antiretroviral therapy · Cohort · Cohort study · Family medicine · Human immunodeficiency virus (HIV) · Immune system · Specialty · Viral load · HIV Research and Treatment · HIV/AIDS drug development and treatment · HIV/AIDS Research and Interventions · Immunology · Internal Medicine · Medicine · Pediatrics
Highly Active Antiretroviral Therapy in a Large Urban Clinic
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
| Unique citing works | 2 |
|---|---|
| Citations per year | 0,17 |
| Citation span | 2014 - 2026 (13) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 2 |